ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 56 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,283,552 | -2.7% | 4,189,034 | +3.1% | 0.00% | – |
| Q2 2023 | $6,458,634 | +117.3% | 4,062,034 | -2.0% | 0.00% | – |
| Q1 2023 | $2,972,282 | +28.1% | 4,143,131 | +3.5% | 0.00% | – |
| Q4 2022 | $2,319,757 | -39.0% | 4,003,031 | +0.0% | 0.00% | – |
| Q3 2022 | $3,801,000 | -23.8% | 4,001,205 | -3.8% | 0.00% | – |
| Q2 2022 | $4,989,000 | +7.7% | 4,157,605 | +17.6% | 0.00% | – |
| Q1 2022 | $4,632,000 | -38.0% | 3,536,364 | -16.7% | 0.00% | – |
| Q4 2021 | $7,471,000 | -21.4% | 4,244,950 | -3.1% | 0.00% | – |
| Q3 2021 | $9,502,000 | -37.5% | 4,378,759 | +0.8% | 0.00% | – |
| Q2 2021 | $15,211,000 | -66.3% | 4,345,771 | -5.2% | 0.00% | -100.0% |
| Q1 2021 | $45,199,000 | -6.9% | 4,584,040 | +2.3% | 0.00% | 0.0% |
| Q4 2020 | $48,553,000 | +7.6% | 4,478,951 | +2.2% | 0.00% | 0.0% |
| Q3 2020 | $45,126,000 | -43.8% | 4,381,163 | +13.9% | 0.00% | -66.7% |
| Q2 2020 | $80,312,000 | +158.6% | 3,846,430 | +21.0% | 0.00% | +200.0% |
| Q1 2020 | $31,051,000 | -0.8% | 3,178,255 | +17.0% | 0.00% | 0.0% |
| Q4 2019 | $31,298,000 | +109.4% | 2,716,868 | -0.9% | 0.00% | 0.0% |
| Q3 2019 | $14,945,000 | -50.2% | 2,742,221 | +8.6% | 0.00% | 0.0% |
| Q2 2019 | $30,016,000 | +170.5% | 2,524,477 | +19.2% | 0.00% | – |
| Q1 2019 | $11,095,000 | +113.9% | 2,117,514 | +28.6% | 0.00% | – |
| Q4 2018 | $5,188,000 | -61.8% | 1,647,069 | -26.7% | 0.00% | -100.0% |
| Q3 2018 | $13,589,000 | +16.4% | 2,246,018 | +1.9% | 0.00% | – |
| Q2 2018 | $11,678,000 | +10.8% | 2,203,334 | +21.2% | 0.00% | – |
| Q1 2018 | $10,540,000 | +251.3% | 1,817,377 | +112.0% | 0.00% | – |
| Q4 2017 | $3,000,000 | -9.1% | 857,108 | -5.2% | 0.00% | – |
| Q3 2017 | $3,299,000 | +140.8% | 903,860 | +65.0% | 0.00% | – |
| Q2 2017 | $1,370,000 | -19.5% | 547,748 | -13.1% | 0.00% | – |
| Q1 2017 | $1,702,000 | +20.8% | 630,302 | +29.8% | 0.00% | – |
| Q4 2016 | $1,409,000 | -47.9% | 485,779 | -26.2% | 0.00% | – |
| Q3 2016 | $2,705,000 | +24.1% | 658,188 | -4.6% | 0.00% | – |
| Q2 2016 | $2,180,000 | – | 689,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |